AAAAAA
Results: 1-25/28
Authors:
Griebel, G
Perrault, G
Soubrie, P
Citation: G. Griebel et al., Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents, PSYCHOPHAR, 158(3), 2001, pp. 241-251
Authors:
Brodeur, J
Vyskocil, A
Tardif, R
Perrault, G
Drolet, D
Truchon, G
Lemay, F
Citation: J. Brodeur et al., Adjustment of permissible exposure values to unusual work schedules, AIHAJ, 62(5), 2001, pp. 584-594
Authors:
Scatton, B
Cohen, C
Perrault, G
Oblin, A
Claustre, Y
Schoemaker, H
Sanger, DJ
Rouquier, L
Porsolt, R
Citation: B. Scatton et al., The preclinical pharmacologic profile of tiapride, EUR PSYCHIA, 16, 2001, pp. 29S-34S
Authors:
Griebel, G
Perrault, G
Simiand, J
Cohen, C
Granger, P
Decobert, M
Francon, D
Avenet, P
Depoortere, H
Tan, S
Oblin, A
Schoemaker, H
Evanno, Y
Sevrin, M
George, P
Scatton, B
Citation: G. Griebel et al., SL651498: An anxioselective compound with functional selectivity for alpha(2)- and alpha(3)-containing gamma-aminobutyric acid(A) (GABA(A)) receptors, J PHARM EXP, 298(2), 2001, pp. 753-768
Authors:
Griebel, G
Belzung, C
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice, PSYCHOPHAR, 148(2), 2000, pp. 164-170
Authors:
Boulay, D
Depoortere, R
Perrault, G
Sanger, DJ
Citation: D. Boulay et al., Decreased locomotor activity after microinjection of dopamine D-2/D-3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D-3 receptor mediated effect?, PROG NEUR-P, 24(1), 2000, pp. 39-49
Authors:
Depoortere, R
Perrault, G
Sanger, DJ
Citation: R. Depoortere et al., The D-3 antagonist PNU-99194A potentiates the discriminative cue produced by the D-3 agonist 7-OH-DPAT, PHARM BIO B, 65(1), 2000, pp. 31-34
Authors:
Griebel, G
Rodgers, RJ
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., The effects of compounds varying in selectivity as 5-HT1A receptor antagonists in three rat models of anxiety, NEUROPHARM, 39(10), 2000, pp. 1848-1857
Authors:
Boulay, D
Depoortere, R
Oblin, A
Sanger, DJ
Schoemaker, H
Perrault, G
Citation: D. Boulay et al., Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice, EUR J PHARM, 391(1-2), 2000, pp. 63-73
Authors:
Griebel, G
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Subtype-selective benzodiazepine receptor ligands, MIL DRUG TH, 2000, pp. 77-94
Authors:
Griebel, G
Perrault, G
Letang, V
Granger, P
Avenet, P
Schoemaker, H
Sanger, DJ
Citation: G. Griebel et al., New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes, PSYCHOPHAR, 146(2), 1999, pp. 205-213
Authors:
Griebel, G
Rodgers, RJ
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT1A receptor antagonists, PSYCHOPHAR, 144(2), 1999, pp. 121-130
Authors:
Depoortere, R
Perrault, G
Sanger, DJ
Citation: R. Depoortere et al., Intracranial self stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol, PSYCHOPHAR, 142(3), 1999, pp. 221-229
Authors:
Cohen, C
Perrault, G
Sanger, DJ
Citation: C. Cohen et al., Effects of D-1 dopamine receptor agonists on oral ethanol self administration in rats: comparison with their efficacy to produce grooming and hyperactivity, PSYCHOPHAR, 142(1), 1999, pp. 102-110
Authors:
Dufresne, A
Perrault, G
Yamato, H
Masse, S
Begin, R
Citation: A. Dufresne et al., Clearance of man made mineral fibres from the lungs of sheep, OCC ENVIR M, 56(10), 1999, pp. 684-690
Authors:
Griebel, G
Perrault, G
Tan, S
Schoemaker, H
Sanger, DJ
Citation: G. Griebel et al., Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands, BEHAV PHARM, 10(5), 1999, pp. 483-495
Authors:
Depoortere, R
Perrault, G
Sanger, DJ
Citation: R. Depoortere et al., Prepulse inhibition of the startle reflex in rats: effects of compounds acting at various sites on the NMDA receptor complex, BEHAV PHARM, 10(1), 1999, pp. 51-62
Authors:
Griebel, G
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: Evaluation of the importance of intrinsic efficacy and receptor subtype selectivity, PROG NEUR-P, 23(1), 1999, pp. 81-98
Authors:
Cohen, C
Curet, O
Perrault, G
Sanger, DJ
Citation: C. Cohen et al., Reduction of oral ethanol self-administration in rats by monoamine oxidaseinhibitors, PHARM BIO B, 64(3), 1999, pp. 535-539
Authors:
Sanger, DJ
Griebel, G
Perrault, G
Claustre, Y
Schoemaker, H
Citation: Dj. Sanger et al., Discriminative stimulus effects of drugs acting at GABA(A) receptors: Differential profiles and receptor selectivity, PHARM BIO B, 64(2), 1999, pp. 269-273
Authors:
Griebel, G
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice, PHARM BIO B, 62(4), 1999, pp. 689-694
Authors:
Griebel, G
Cohen, C
Perrault, G
Sanger, DJ
Citation: G. Griebel et al., Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats, PHYSL BEHAV, 67(3), 1999, pp. 315-320
Authors:
Boulay, D
Depoortere, R
Perrault, G
Borrelli, E
Sanger, DJ
Citation: D. Boulay et al., Dopamine D-2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D-2/D-3 receptor agonists, NEUROPHARM, 38(9), 1999, pp. 1389-1396
Authors:
Griebel, G
Perrault, G
Tan, S
Schoemaker, H
Sanger, DJ
Citation: G. Griebel et al., Pharmacological studies on synthetic flavonoids: comparison with diazepam, NEUROPHARM, 38(7), 1999, pp. 965-977
Authors:
Boulay, D
Depoortere, R
Rostene, W
Perrault, G
Sanger, DJ
Citation: D. Boulay et al., Dopamine D-3 receptor agonists produce similar decreases in body temperature and locomotor activity in D-3 knock-out and wild-type mice, NEUROPHARM, 38(4), 1999, pp. 555-565